bambermycin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| antibiotics, produced by Streptomyces strains | 5603 | 11015-37-5 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
Antibiotic complex obtained from Streptomyces bambergiensis containing mainly Moenomycins and C. They are used as feed additives and growth promoters for poultry, swine, and cattle
|
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| MeSH PA | D000900 | Anti-Bacterial Agents |
| MeSH PA | D000890 | Anti-Infective Agents |
| CHEBI has role | CHEBI:33281 | antibiotics |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
| Species | Use | Relation |
|---|---|---|
| Chickens | To increase rate of weight gain | Indication |
| Chickens | To improve feed efficiency | Indication |
| Swine | To increase rate of weight gain | Indication |
| Swine | To improve feed efficiency | Indication |
| Turkeys | To increase rate of weight gain | Indication |
| Turkeys | To improve feed efficiency | Indication |
🐶 Veterinary products
| Product | Applicant | Ingredients |
|---|---|---|
| Flavomycin 4 | Huvepharma EOOD | 1 |
| Amprol HI-E & Bambermycins, Amprol HI-E / Flavomycin | Huvepharma EOOD | 3 |
| Flavomycin / Monensin | Huvepharma EOOD | 2 |
| Flavomycin / Zoalene | Huvepharma EOOD | 2 |
| Flavomycin and Amprol/ Amprol 25% and Flavomycin | Huvepharma EOOD | 2 |
| Flavomycin | ADM Animal Nutrition | 1 |
| Bio-Cox / Flavomycin | Huvepharma EOOD | 2 |
| Flavomycin / Stenorol | Huvepharma EOOD | 2 |
| Nicarbazin (NICARB) plus Bambermycins (FLAVOMYCIN) | Huvepharma EOOD | 2 |
| Flavomycin / Monteban | Huvepharma EOOD | 2 |
| Flavomycin / Stenorol | Huvepharma EOOD | 2 |
| Flavomycin / Maxiban | Elanco US Inc. | 3 |
| Coban / Flavomycin | Elanco US Inc. | 2 |
| GAINPRO 10 | Huvepharma EOOD | 1 |
| Avatec / Flavomycin | Huvepharma EOOD | 2 |
| Clinacox and Flavomycin | Elanco US Inc. | 2 |
| Clinacox and Flavomycin | Elanco US Inc. | 2 |
| Coyden and Flavomycin | Huvepharma EOOD | 2 |
| Flavomycin / Sacox | Huvepharma EOOD | 2 |
Acid dissociation constants calculated using MoKa v3.0.0
None
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| CHEBI:28908 | CHEBI |
| CHEMBL2108902 | ChEMBL_ID |
| DB11377 | DRUGBANK_ID |
| C0004717 | UMLSCUI |
| 373560000 | SNOMEDCT_US |
| 96149000 | SNOMEDCT_US |
| 2666 | INN_ID |
| D03050 | KEGG_DRUG |
| 6433554 | PUBCHEM_CID |
| 1367176 | RXNORM |
| D001455 | MESH_DESCRIPTOR_UI |
| PP922A42V2 | UNII |
Pharmaceutical products:
None